You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BEAC

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Large B-Cell, Diffuse, Mantle Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Nanjing (Chidamide)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Dec 30, 2021

Peripheral T-cell Lymphoma Trial in Shanghai (BEAC, Cladribine combined with BEAC)

Recruiting
  • Peripheral T-cell Lymphoma
  • BEAC
  • Cladribine combined with BEAC
  • Shanghai, Shanghai, China
    Ruijin Hospital
May 9, 2021

T Cell Lymphoma Trial in Shanghai (Chidamide combined with BEAM)

Recruiting
  • T Cell Lymphoma
  • Chidamide combined with BEAM
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 27, 2022

Lymphoma Trial in Omaha (PBSCT, Bone Marrow Transplant)

Completed
  • Lymphoma
  • PBSCT
  • Bone Marrow Transplant
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jan 13, 2018

Lymphoma Trial in Omaha (131Iodine-Anti-B1 Radioimmunotherapy)

Completed
  • Lymphoma
  • 131Iodine-Anti-B1 Radioimmunotherapy
  • Omaha, Nebraska
    University of Nebraska Medical Center
May 1, 2017

Type 2 Diabetes Trial in Zerifin (Stimulator)

Completed
  • Type 2 Diabetes Mellitus
  • Stimulator
  • Zerifin, Israel
    Assaf-Harofeh Medical Center
Jun 6, 2016

Waldenström Macroglobulinemia Trial in Tianjin (autologous stem cell transplantation, conventional chemo)

Unknown status
  • Waldenström Macroglobulinemia
  • autologous stem cell transplantation
  • conventional chemotherapy
  • Tianjin, China
    Shuhua Yi
Jul 25, 2016

Myeloma, Plasma-Cell, Lymphoma, Malignant Trial in Kansas City (Palonosetron, Aprepitant, Dexamethasone)

Completed
Has Results
  • Myeloma, Plasma-Cell
  • Lymphoma, Malignant
  • Kansas City, Kansas
    University of Kansas Medical Center
Jan 18, 2017

Non-Hodgkin Lymphoma Trial in Busan, Seoul, Ulsan (Busulfan, etoposide, cytarabine, and melphalan)

Unknown status
  • Non-Hodgkin Lymphoma
  • Busulfan, etoposide, cytarabine, and melphalan
  • Busan, Korea, Republic of
  • +4 more
Aug 22, 2014

Non-Hodgkin Lymphoma Trial in Busan, Seoul, Ulsan (Busulfan, etoposide, cytarabine, and melphalan)

Unknown status
  • Non-Hodgkin Lymphoma
  • Busulfan, etoposide, cytarabine, and melphalan
  • Busan, Korea, Republic of
  • +4 more
Aug 22, 2014

Mantle Cell Lymphoma Trial in Oslo (90Y-ibritumomab tiuxetan (Zevalin))

Completed
  • Mantle Cell Lymphoma
  • 90Y-ibritumomab tiuxetan (Zevalin)
  • Oslo, Norway
    Arne Kolstad
May 3, 2012

Nausea, Vomiting Trial in Uppsala (Aprepitant (Emend), Placebo)

Completed
  • Nausea
  • Vomiting
  • Aprepitant (Emend)
  • Placebo
  • Uppsala, Sweden
    Uppsala University Hospital
Dec 12, 2012

Non Hodgkin's Lymphoma Trial in Busan, Seoul, Ulsan (Busulfan, Etoposide, Cytarabine, Melphalan)

Unknown status
  • Non Hodgkin's Lymphoma
  • Busulfan, Etoposide, Cytarabine, Melphalan
  • Busan, Korea, Republic of
  • +4 more
Dec 1, 2010